RGAGX | USLCX | RGAGX / USLCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 23 years | - |
Gain YTD | 3.125 | 1.958 | 160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304B | 2.22B | 13,688% |
Annual Yield % from dividends | 0.75 | 0.00 | - |
Returns for 1 year | 12.78 | -10.22 | -125% |
Returns for 3 years | 24.04 | 3.16 | 762% |
Returns for 5 years | 44.25 | 1.56 | 2,828% |
Returns for 10 years | 75.55 | 20.25 | 373% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EITEX | 41.36 | -0.18 | -0.43% |
Parametric Tax-Managed Emerg Mkt I | |||
OTTRX | 14.93 | -0.26 | -1.71% |
Otter Creek Long/Short Opportunity Instl | |||
SMVLX | 79.75 | -1.58 | -1.94% |
Smead Value Investor | |||
LHCSX | 19.71 | -0.39 | -1.94% |
Lord Abbett Health Care R4 | |||
FSSLX | 11.87 | -0.35 | -2.86% |
Fidelity Series Small Cap Core |